Literature DB >> 2429672

Deficient gamma-interferon production in patients with systemic lupus erythematosus.

G C Tsokos, D T Boumpas, P L Smith, J Y Djeu, J E Balow, A H Rook.   

Abstract

We examined the ability of peripheral mononuclear cells (MNC) from patients with systemic lupus erythematosus (SLE) to produce gamma-interferon (gamma-IFN) in vitro. MNC from patients with SLE produced varying amounts of gamma-IFN upon mitogenic stimulation. However, they produced distinctly decreased amounts of gamma-IFN upon in vitro stimulation with interleukin-2 (IL-2). Deficient production seemed to be primary, rather than secondary to either excessive monocytic suppression or failure of IL-2 to bind to the MNC surface membranes. gamma-IFN-specific RNA transcription, as determined by slot-blot analysis, was severely decreased in MNC that had been stimulated with phytohemagglutinin or IL-2. These findings suggest that MNC of patients with SLE have defects in the IL-2 signal transduction which is required for production of gamma-IFN.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2429672     DOI: 10.1002/art.1780291005

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  16 in total

Review 1.  Systemic lupus erythematosus: RNA-protein autoantigens, models of disease heterogeneity, and theories of etiology.

Authors:  J B Harley; R H Scofield
Journal:  J Clin Immunol       Date:  1991-11       Impact factor: 8.317

2.  Th1 (IL-2, interferon-gamma (IFN-gamma)) and Th2 (IL-10, IL-4) cytokine production by peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE).

Authors:  J F Viallard; J L Pellegrin; V Ranchin; T Schaeverbeke; J Dehais; M Longy-Boursier; J M Ragnaud; B Leng; J F Moreau
Journal:  Clin Exp Immunol       Date:  1999-01       Impact factor: 4.330

3.  SLAMF6-driven co-stimulation of human peripheral T cells is defective in SLE T cells.

Authors:  Madhumouli Chatterjee; Katalin Kis-Toth; To-Ha Thai; Cox Terhorst; George C Tsokos
Journal:  Autoimmunity       Date:  2011-01-14       Impact factor: 2.815

Review 4.  The cytokine network in the pathogenesis of systemic lupus erythematosus and possible therapeutic implications.

Authors:  D A Horwitz; C O Jacob
Journal:  Springer Semin Immunopathol       Date:  1994

Review 5.  The role of cytokines in the immunopathogenesis of lupus.

Authors:  B S Handwerger; V Rus; L da Silva; C S Via
Journal:  Springer Semin Immunopathol       Date:  1994

6.  Absence of peripheral blood T cell responses to "shared epitope' containing peptides in recent onset rheumatoid arthritis.

Authors:  G J McColl; J Hammer; L C Harrison
Journal:  Ann Rheum Dis       Date:  1997-04       Impact factor: 19.103

7.  Trichostatin A reverses skewed expression of CD154, interleukin-10, and interferon-gamma gene and protein expression in lupus T cells.

Authors:  N Mishra; D R Brown; I M Olorenshaw; G M Kammer
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-20       Impact factor: 11.205

8.  Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys.

Authors:  José C Crispín; Mohamed Oukka; George Bayliss; Robert A Cohen; Christine A Van Beek; Isaac E Stillman; Vasileios C Kyttaris; Yuang-Taung Juang; George C Tsokos
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

Review 9.  Cytokines in systemic lupus erythematosus.

Authors:  Elaine V Lourenço; Antonio La Cava
Journal:  Curr Mol Med       Date:  2009-04       Impact factor: 2.222

10.  Circulating intercellular adhesion molecule 1 as a new activity marker in patients with systemic lupus erythematosus.

Authors:  E Kling; S Bieg; M Boehme; W A Scherbaum
Journal:  Clin Investig       Date:  1993-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.